Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data

被引：0
|
作者：
James B. Young
Marjolaine Gauthier-Loiselle
Robert A. Bailey
Ameur M. Manceur
Patrick Lefebvre
Morris Greenberg
Marie-Hélène Lafeuille
Mei Sheng Duh
Brahim Bookhart
Carol H. Wysham
机构：
[1] Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University,
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Analysis Group Inc.,undefined
[7] Rockwood Clinic,undefined
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Type 2 diabetes mellitus; Cardiovascular disease; Risk prediction; Health insurance claims;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Associations between migraine and major cardiovascular events in type 2 diabetes mellitus
    Cheon, Dae Young
    Han, Kyungdo
    Yang, Ye Seul
    Kim, Yerim
    Lee, Sang-Hwa
    Kim, Chulho
    Sohn, Jong-Hee
    Oh, Mi Sun
    Lee, Byung-Chul
    Lee, Minwoo
    Yu, Kyung-Ho
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [32] The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
    Xu, Shuai
    Qin, Zhen
    Yuan, Ruixia
    Cui, Xiaolin
    Zhang, Li
    Bai, Jing
    Liu, Gangqiong
    Wang, Zeyu
    Yu, Fengyi
    Lv, Yan
    Zhang, Jinying
    Tang, Junnan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [33] Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
    Brownrigg, Jack R. W.
    de Lusignan, Simon
    McGovern, Andrew
    Hughes, Cian
    Thompson, Matthew M.
    Ray, Kausik K.
    Hinchliffe, Robert J.
    HEART, 2014, 100 (23) : 1837 - +
  • [34] The predictive value of lesion-specific pericoronary fat attenuation index for major adverse cardiovascular events in patients with type 2 diabetes
    Liu, Meiju
    Zhen, Yanhua
    Shang, Jin
    Dang, Yuxue
    Zhang, Qian
    Ni, Weishi
    Qiao, Yujuan
    Hou, Yang
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [35] DIFFERENTIAL FACTORS PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ATHEROSCLEROTIC PATIENTS WITH AND WITHOUT DIABETES MELLITUS
    Lin, F.
    Tseng, W.
    Wu, Y.
    Yin, W.
    Li, Y.
    Yeh, H.
    Chen, J.
    Wu, C.
    VALUE IN HEALTH, 2016, 19 (07) : A864 - A864
  • [36] Sulfonylureas and the Risk of Adverse Cardiovascular Events Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
    Filion, Kristian B.
    Azoulay, Laurent
    Yin, Hui
    Yu, Oriana H.
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 46 - 46
  • [37] Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data
    Huang, Yunyu
    Vemer, Pepijn
    Zhu, Jingjing
    Postma, Maarten J.
    Chen, Wen
    PLOS ONE, 2016, 11 (08):
  • [38] Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events A Post Hoc Analysis of a Randomized Clinical Trial
    Verma, Subodh
    Bain, Stephen C.
    Buse, John B.
    Idorn, Thomas
    Rasmussen, Soren
    Orsted, David D.
    Nauck, Michael A.
    JAMA CARDIOLOGY, 2019, 4 (12) : 1214 - 1220
  • [39] Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan
    Hsiao, Fei-Yuan
    Huang, Weng-Foung
    Wen, Yu-Wen
    Chen, Pei-Fen
    Kuo, Ken N.
    Tsai, Yi-Wen
    DRUG SAFETY, 2009, 32 (08) : 675 - 690
  • [40] Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin
    McMurray, John J. V.
    Solomon, Scott D.
    Lock, J. Paul
    Massaro, Joseph M.
    Zhu, Fang
    Zhou, Wenjiong
    Skali, Hicham
    Lewis, Eldrin F.
    Freeman, Mason W.
    Halvorsen, Yuan-Di C.
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 971 - 979
12345